Andere Kunden interessierten sich auch für
![Formulation and Evaluation of Sublingual Tablet of Rabeprazole Sodium]( "Formulation and Evaluation of Sublingual Tablet of Rabeprazole Sodium")
Formulation and Evaluation of Sublingual Tablet of Rabeprazole Sodium40,99 €![Formulation and Evaluation of Rabeprazole sodium microspheres]( "Formulation and Evaluation of Rabeprazole sodium microspheres")
Formulation and Evaluation of Rabeprazole sodium microspheres32,99 €![Design and Development of Extended Release Tablet of Nicotinic acid]( "Design and Development of Extended Release Tablet of Nicotinic acid")
Design and Development of Extended Release Tablet of Nicotinic acid38,99 €![Process Optimization of Diclofenac Sodium Sustained Release Tablet]( "Process Optimization of Diclofenac Sodium Sustained Release Tablet")
Process Optimization of Diclofenac Sodium Sustained Release Tablet32,99 €![Preparation and evaluation of diclofenac sodium gel using natural gum]( "Preparation and evaluation of diclofenac sodium gel using natural gum")
Preparation and evaluation of diclofenac sodium gel using natural gum32,99 €![Formulation and development of diclofenac and rabeprazole microspheres]( "Formulation and development of diclofenac and rabeprazole microspheres")
Formulation and development of diclofenac and rabeprazole microspheres32,99 €![Design and Development of Time Dependent Montelukast Sodium Tablet]( "Design and Development of Time Dependent Montelukast Sodium Tablet")
Design and Development of Time Dependent Montelukast Sodium Tablet36,99 €
The present invention is aimed to formulate the non-enteric formulation of immediate release rabeprazole sodium tablet using acid-buffer technology. The formulation comprising the core tablet containing rabeprazole sodium compression coated with buffer containing super disintegrant. The coat formulation disintegrates fast which provide the higher pH environment then the core formulation gives drug release so degradation of rabeprazole sodium can prevent. From the above perception, the invention is aimed: 1.To study the pH stability of rabeprazole sodium in at different pH medium. 2.To select the proper buffer combination for better basic environment. 3.To formulate the fast release compression coated tablet of rabeprazole sodium. 4.To optimize the formulation using suitable experimental design.